Precision oncology and you.
At Helomics we believe cancer therapy should be personal and that’s why we harness the power of your tumor to do just that. Our unique platform interrogates your living tumor tissue using a set of genomic and functional tests that determine both your tumor’s mutations and how your tumor responds to drugs. This information can help your oncologist individualize your therapy to your unique tumor.
Why have your tumor tested at Helomics?
Because your cancer can undergo therapy
before you do.
Your oncologist is using every tool available to improve the odds in your fight against cancer. At Helomics we complement your oncologist’s efforts with our holistic approach to testing your tumor. This approach combines drug response profiling and genomic profiling of your tumor, generating a comprehensive picture to provide information to help your oncologist individualize your therapy. This information may be used to reduce your risk of receiving therapies that are ineffective or to identify alternatives when the typical treatments recommended for your type of cancer cannot be tolerated. We firmly believe that this unique Tumor Drug Response Profiling (TDRP) platform, together with the latest NGS-based genomic profiling and our vast cancer knowledgebase of 150K+ tumors, will provide a more functional approach. Relying on precision medicine, rather than genomics alone, will help guide your oncologist’s therapy decisions.
How does your tumor get tested?
Demonstrated clinical utility as a prognostic and predictive drug response marker
Tumor tissue is obtained during surgery and your oncologist will send that tissue to our CLIA certified laboratory using our special collection kit. Two samples of your tumor tissue are obtained, fixed and live. The fixed tumor tissue is used for a panel of genomic biomarker tests. The live tumor tissue is grown in the lab and used to test the drug response of the tumor to a panel of standard-of-care (SOC) drugs. When testing is complete a report is provided back to your clinician with recommended SOC therapies based on the drug response and genomic profiles.
What is the value of your tumor being tested?
In addition to helping you, your tumor will help future patients.
The data generated from testing the unique mutations of your tumor and from the drug response profiling, which essentially performs chemotherapy on your tumor outside of the body, provides information to your oncologist to improve the odds in your fight against cancer. In addition, and with your consent, data generated by testing your tumor is added to our cancer knowledgebase of existing tumor data. Deeper analysis of this data will improve the recommendations we give to clinicians to help patients like you, as well as provide insights to guide research into new therapies for GYN cancers.
How much will it cost?
We understand the financial stresses cancer diagnosis and treatment can bring and we are here for you.
Helomics is committed to providing access to functional precision medicine to as many people as possible. Our panel of biomarker/genomic tests are covered by most insurers/Medicare. We have continued to offer ChemoFx Tumor Drug Response Profiling (TDRP) amidst reimbursement uncertainty from both commercial insurers and Medicare. Due to continued clinical demand and interest in our TDRP panel across the GYN-ONC community, we remain committed to meeting the needs of patients. To keep this testing available to patients and their treating physicians, Helomics offers our Tumor Drug Response Profiling at a drastically reduced rate such that no patient will pay more than $615.00. We also provide a Compassionate Care Program for those patients who need further help with payment.
Frequently asked questions:
What is tumor drug response testing?
Drug Response profiling is a treatment selection marker. It determines how an individual gynecologic cancer patient is likely to respond to the various types of chemotherapy by testing the treatment options on that patients live cancer cells and measuring cell response. This provides valuable insights that help guide physicians’ treatment decisions, giving you an edge against gynecologic cancer.
Why tumor drug response testing?
Your physician is using every advantage available to improve the odds in your fight against cancer. Drug Response Profiling is designed to reduce your risk of receiving therapies that are ineffective or to identify alternatives when the typical treatments recommended for your type of cancer cannot be tolerated.
What is genomic testing?
Genomic testing is a group of clinically relevant cancer-related biomarker tests that look to your genetics to predict your cancer’s response to various types of chemotherapy and/or the course your disease is likely to take. The biomarkers included in Genomic testing are well-validated and supported by current research and key opinion leaders.